• 116 Citations
  • 6 h-Index
20162018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Federico Pozzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Mutation Medicine & Life Sciences
Ribosomes Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Histone Deacetylases Medicine & Life Sciences
Small Interfering RNA Medicine & Life Sciences
Genes Medicine & Life Sciences
Transfection Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2018

  • 116 Citations
  • 6 h-Index
  • 9 Article
  • 3 Letter

NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: Link between the NOTCH1 and the NF-κ B pathways

Benedetti, D., Tissino, E., Pozzo, F., Bittolo, T., Caldana, C., Perini, C., Martorelli, D., Bravin, V., D'Agaro, T., Rossi, F. M., Bomben, R., Santinelli, E., Zaja, F., Pozzato, G., Chiarenza, A., Di Raimondo, F., Del Poeta, G., Rossi, D., Gaidano, G., Dal Bo, M. & 2 others, Gattei, V. & Zucchetto, A., Mar 1 2018, In : Leukemia. 32, 3, p. 654-662 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Mutation
Trisomy
Integrins
Disease Progression
5 Citations (Scopus)

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Bulian, P., Bomben, R., Dal Bo, M., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D’Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D’Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Del Poeta, G., Gaidano, G., Shanafelt, T. D. & Gattei, V., Oct 27 2017, In : Haematologica. 102, 11, p. e443-e446

Research output: Contribution to journalLetter

5 Citations (Scopus)

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Bulian, P., Bomben, R., Bo, M. D., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D'Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D'Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Poeta, G. D., Gaidano, G., Shanafelt, T. D. & Gattei, V., Nov 2017, In : Haematologica. 102, 11, p. e443-e446

Research output: Contribution to journalArticle

5 Citations (Scopus)

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Bulian, P., Bomben, R., Dal Bo, M., Zucchetto, A., Rossi, F. M., Degan, M., Pozzo, F., Bittolo, T., Bravin, V., D’Agaro, T., Cerri, M., Chiarenza, A., Chaffee, K. G., Condoluci, A., D’Arena, G., Spina, M., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D. & 4 others, Del Poeta, G., Gaidano, G., Shanafelt, T. D. & Gattei, V., Oct 27 2017, In : Haematologica. 102, 11, p. e443-e446 3 p.

Research output: Contribution to journalLetter

8 Citations (Scopus)

Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia

Bittolo, T., Pozzo, F., Bomben, R., D’Agaro, T., Bravin, V., Bulian, P., Rossi, F. M., Zucchetto, A., Degan, M., Macor, P., D’Arena, G., Chiarenza, A., Zaja, F., Pozzato, G., Di Raimondo, F., Rossi, D., Gaidano, G., Del Poeta, G., Gattei, V. & Dal Bo, M., Jul 31 2017, In : Haematologica. 102, 8, p. e305-e309

Research output: Contribution to journalLetter